Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Study of Uridine Triacetate in Pediatric Patients With Hereditary Orotic Aciduria

NCT02110147 is registered in ClinicalTrials.gov with Wellstat Therapeutics as lead sponsor.

NCT NCT02110147
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02110147 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Study of Uridine Triacetate in Pediatric Patients With Hereditary Orotic Aciduria
Lead sponsor
Wellstat Therapeutics
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2014
Completion date
September 8, 2016
Enrollment
4 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hereditary orotic aciduria